Pediatricians
- Pediatricians play an important role in the perinatal Hepatitis
B prevention program (PHPP) in preventing Hepatitis B transmission
from mother to baby.
- By collaborating with
our nurse case managers, we can ensure that infants receive their
Hepatitis B vaccines in a timely manner and are tested to determine
immunity and infection.
- We encourage you to review the information below to see what California Department of Public Health (CDPH) recommends for all pediatricians to do when taking care of infants that are part of our program.
6 Actions to Complete
1) Ask about maternal history regarding Hepatitis B status
2) Contact our program to notify us that an infant exposed to Hepatitis B at birth is under your care
3) Check infant's birth record to ensure post exposure prophylaxis (PEP) was administered
- Consists of both Hepatitis B vaccine and Hepatitis B Immune Globulin (HBIG)
- Both should have been administered within 12 hours of birth
- Should have been administered in separate limbs.
4) Review and educate parents on Hepatitis B vaccine schedule
Infant birth weight ≥ 2000 grams | Infant birth weight < 2000 grams | |||
Single antigen | Combination | Single antigen | Combination | |
Birth dose (within 12 hrs of birth) | 1st dose of Hepatitis B vaccine + Hepatitis B Immune Globulin (1st dose is always single antigen vaccine) | |||
1 month | 2nd dose | 2nd dose | ||
2 months | 2nd dose | 3rd dose (between 2-3 months) | 2nd dose | |
4 months | 3rd dose | 3rd dose | ||
6 months | 3rd dose | 4th dose | 4th dose | 4th dose |
5) Administer and document Hepatitis B vaccines given according to ACIP recommended schedule
6) Complete Post-Vaccination Serology Testing (PVST) when child is 9-12 months of age
- PVST should be ordered when the following criteria are
met:
- Child has completed 3-4 dose Hepatitis B vaccine
series
- Child is at least 9 months old and last dose of Hepatitis B vaccine was administered 1 to 2 months ago
- Child has completed 3-4 dose Hepatitis B vaccine
series
- PVST includes both Hepatitis B surface antigen (HBsAg) and Hepatitis B surface antibody (quantitative)
- Interpreting results - review CDC's table below
Please report the PVST results to us as soon as they are available by sending the laboratory reports via secure email or fax:
- Secure email: PHS-PerinatalHepB.HHSA@sdcounty.ca.gov
- Fax: 619-692-5677
PVST can be collected too early.
If Post-Vaccination Serology Testing (PVST) is collected prior to the child being 9 months of age, or before a month has passed since the last dose was administered, it may yield inaccurate test results. Please see examples below.
- Hepatitis B surface antigen may be falsely positive if the vaccine was recently given, and the lab was collected within one month of the dose being administered.
- Hepatitis B surface antigen can also result as negative if collected too early, as a result of the infant receiving HBIG.
- Hepatitis B surface antibody may be falsely positive when collected too early as a result of the antibodies that are passed from the mother to baby, along with the administration of HBIG.
PVST can still be collected even if a significant amount of time has passed, and the child is older than 12 months of age.
However, it is important to note that antibody levels significantly decline within the first year after vaccination, which is why it is important to complete the PVST as soon as the infant is eligible. If more than 6 months have passed since the last dose was given and PVST hasn’t been completed, you may consider providing the infant with an additional dose of Hepatitis B vaccine and then completing the PVST 1-2 months after the vaccine has been administered.
Resources and Additional Information
We really appreciate your assistance and continued cooperation to help make the perinatal Hepatitis B prevention program a success in San Diego County.
Please see some additional resources below regarding pediatrician guidance.
- County of San Diego Perinatal Hepatitis B: Pediatrician Information Sheet
- CDPH Pediatric Provider Quicksheet
- Management of Infants Born to Women with Hepatitis B Virus Infection
- Interpretation of Hepatitis B Serologic Test Results
- CDPH: Perinatal Hepatitis B Prevention Program
- Vaccine Information Statement for Hepatitis B (VIS)